Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Endo International
Pharma
Trial results set up Keenova to gain 3rd indication for Xiaflex
A positive phase 3 trial of patients with plantar fibromatosis could set Keenova Therapeutics’ Xiaflex up for approval in a third indication.
Kevin Dunleavy
Jul 8, 2026 11:27am
Citing labeling glitch, Endo expands clonazepam recall
Nov 19, 2024 1:52pm
Par Pharma recalls blood pressure med for possible contamination
Apr 22, 2024 9:50am
Endo brings men to the pool hall for straight talk on Peyronie's
Nov 30, 2023 11:07am
Phase 2 flop causes Endo's frozen shoulder plan to come unstuck
Jul 5, 2022 8:45am
